FDA Approved: VELETRI — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VELETRI (epoprostenol) from Actelion Pharmaceuticals US, Inc., resulting in a labeling update for the medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• VELETRI (EPOPROSTENOL)

Snippet

SUPPL AP for VELETRI (EPOPROSTENOL)